What's the Difference Between Cymbalta and Lexapro?
Lexapro is an SSRI that acts on serotonin. Cymbalta is an SNRI that also acts on norepinephrine, is approved for chronic pain and has a much shorter half-life.
By withClaro Editorial · 2026-11-16 · 8 min read
Clinical section reviewed by Dr. Jason Tan , Consultant Psychiatrist, on October 27, 2026.
Key takeaways Lexapro (escitalopram) is an SSRI. Cymbalta (duloxetine) is an SNRI that acts on serotonin and norepinephrine. Both are FDA-approved for depression and generalized anxiety. Only Cymbalta is approved for nerve pain, fibromyalgia and chronic muscle and joint pain. In head-to-head depression trials, results were similar or slightly favored escitalopram, and fewer people quit it in the short trials. Cymbalta can raise blood pressure a little and carries a liver warning with heavy drinking. With a much shorter half-life, Cymbalta's levels fall faster after a missed dose or a stop.
On this page
What is the difference between Cymbalta and Lexapro? Is Cymbalta more effective than Lexapro? Which is better for anxiety, Cymbalta or Lexapro? Which causes more weight gain and side effects, Lexapro or Cymbalta? Why switch from Lexapro to Cymbalta? Is Cymbalta harder to stop than Lexapro? What should you ask your prescriber when choosing between Lexapro and Cymbalta?
The main difference between Cymbalta and Lexapro is what they act on. Lexapro (escitalopram) is an SSRI that works on serotonin. Cymbalta (duloxetine) is an SNRI that works on serotonin and norepinephrine.
For depression and anxiety, trials put the two close. They part ways on pain, side effects, blood pressure and how fast each one leaves the body.
What is the difference between Cymbalta and Lexapro?
Both treat depression and generalized anxiety, so on those the two overlap. They part ways on pain, which only Cymbalta is approved for. They also differ in half-life, which shapes how a missed dose or a stop feels.
What differs Lexapro (escitalopram) Cymbalta (duloxetine) Drug class SSRI: acts on serotonin SNRI: acts on serotonin and norepinephrine FDA-approved for Depression from age 12, generalized anxiety from age 7 Depression in adults, generalized anxiety from age 7, diabetic nerve pain, fibromyalgia from age 13, chronic muscle and joint pain Usual dose 10 mg once a day, up to 20 mg 40 to 60 mg a day for depression, 60 mg for anxiety and pain Form Tablets Delayed-release capsules, swallowed whole, not chewed, crushed or opened Half-life 27 to 32 hours About 12 hours Most common side effects Nausea, insomnia, delayed ejaculation, sweating, tiredness, sleepiness Nausea, dry mouth, sleepiness, constipation, less appetite, sweating Stopping Lower the dose gradually when possible; withdrawal symptoms listed Lower the dose gradually when possible; withdrawal symptoms listed Extra checks in the label 10 mg for older adults and people with liver problems Blood pressure before and during treatment; not prescribed with heavy drinking or chronic liver disease
If pain is part of why you're being treated, raise it early, since only one of the two is approved for it.
Is Cymbalta more effective than Lexapro?
In three head-to-head trials, duloxetine did not do better than escitalopram for depression. The clearer gap was in how many people stayed on each drug, and that gap shrank in the longest trial.
A 2007 US trial followed 278 outpatients with moderate to severe depression for eight weeks. 87% finished on escitalopram, against 69% on duloxetine. Side effects made 2% stop escitalopram and 13% stop duloxetine. Mood scores favored escitalopram in one analysis and showed no difference in another.
A 2008 analysis pooled two eight-week trials with 564 people. Response was 67% on escitalopram and 53% on duloxetine. The share with few symptoms left was 54% against 44%. Both trials used a fixed duloxetine dose of 60 mg.
The longest comparison, a 2007 trial, ran for eight months with 273 people on duloxetine and 274 on escitalopram. About 70% on duloxetine and 75% on escitalopram ended up with few symptoms left, a gap that could be chance. Over the eight months, 62% stopped duloxetine early and 55% stopped escitalopram. Stopping because of side effects was about 12% to 13% on both.
A 2018 Lancet review of 21 antidepressants pooled 522 trials. Escitalopram was among the drugs people stopped least often, and duloxetine among those with the most dropouts. That ranking mixes many drugs. For this pair, the 2007 and 2008 head-to-head trials are the better guide.
Trial averages can't predict how you will respond. Write down what helped on either drug and what made you want to stop.
Which is better for anxiety, Cymbalta or Lexapro?
Both are FDA-approved for generalized anxiety disorder in adults and in children from age 7, so neither has an edge on paper. We found no randomized trial that compared the two directly for anxiety.
A 2019 Lancet review pooled 89 anxiety trials with 25,441 people. Both duloxetine and escitalopram beat placebo and were fairly well tolerated. Duloxetine's gap from placebo on the anxiety scale was a little larger. The choice often turns on how each one feels in the first weeks. It also matters whether pain or poor sleep comes with the anxiety.
Early side effects matter here. In Cymbalta's depression and anxiety trials, 4% felt agitated and 3% more anxious, against 2% on placebo. In Lexapro's anxiety trials, 12% had insomnia against 6% on placebo, and 13% felt sleepy against 7%. In the eight-month comparison, sleep improved more on escitalopram.
If anxiety is your main concern, say so at the start. Note how your sleep and restlessness change over the first two weeks.
Which causes more weight gain and side effects, Lexapro or Cymbalta?
Neither drug clearly causes more weight gain. In the 2007 eight-month trial, average gain was 1.83 kg (4 lb) on escitalopram and 0.61 kg (1.3 lb) on duloxetine. Yet the share who gained 7% of body weight or more was similar on both.
A 2024 study of 183,118 people's health records compared each drug with sertraline at six months. Escitalopram was linked to about 0.41 kg (0.9 lb) more gain than sertraline, and duloxetine to about 0.34 kg (0.7 lb) more. The gap between the two was under a tenth of a kilogram.
Their side effects differ more in kind than in amount. Cymbalta more often brings nausea, dry mouth and constipation, and it can nudge blood pressure up. Lexapro more often brings sexual side effects in the early weeks.
Side effect, % (placebo) Lexapro, depression trials Cymbalta, depression and anxiety trials Nausea 15 (7) 23 (8) Dry mouth 6 (5) 14 (6) Constipation 3 (1) 9 (4) Sleepiness 6 (2) 9 (3) Insomnia 9 (4) 9 (5) Sweating 5 (2) 6 (2)
Each label tested its drug against its own placebo group. Compare each figure with the placebo number in brackets, not one column with the other.
For women, the two labels read differently on sex. In Lexapro's depression trials, 2% of women could not reach orgasm, against under 1% on placebo. In its anxiety trials, the figure was 6%. On a sexual function scale, Cymbalta showed no clear difference from placebo in women. Its label still warns that SNRIs can lower desire and delay or block orgasm in women.
The 2007 eight-month trial also tracked sex in people who had no sexual problems at the start. At week 8, new problems affected 19 of 39 people on escitalopram and 17 of 51 on duloxetine. After 12 weeks, the gap between the two drugs was no longer significant.
Cymbalta's label asks for blood pressure checks before and during treatment. In the 2007 eight-month trial, systolic pressure rose 3.7 mmHg on duloxetine against 0.3 on escitalopram. Pulse rose about 3 beats a minute on duloxetine.
If your appetite shifts or clothes start to fit differently, mention it at your next appointment. For the full picture on one of the two, see the full list of Cymbalta side effects .
Why switch from Lexapro to Cymbalta? Medically reviewed by Dr. Jason Tan on October 27, 2026, this section only.
The most common reason is pain. Depression or anxiety can come with nerve pain, fibromyalgia or chronic back or joint pain. Cymbalta is approved for both sides, so one drug can cover them. Others switch because Lexapro stopped helping enough, or because a side effect such as sexual problems got in the way.
No antidepressant is the strongest for everyone, and the right one is often found by trying.
In large comparisons most antidepressants work similarly on average, with only modest differences between them. They differ more in side effects, interactions and how hard they are to stop. Needing a second choice does not mean the first was a mistake.
Prescribers look at your main symptoms, other conditions, other medications and past response, yours or a close relative's. Some antidepressants are more activating and others more sedating, which can be matched to problems with sleep or energy.
If a medication has not helped enough after a fair trial, the options include:
adjusting the dose switching to another medication in the same class switching to a different class adding a second medication
Moving from Lexapro to Cymbalta is a switch to a different class. Some people move the other way, when nausea, sweating or blood pressure becomes a problem on Cymbalta. Your prescriber sets the timing and doses, because both drugs raise serotonin. Both labels warn about serotonin syndrome when serotonin drugs are combined. Signs include agitation, heavy sweating, fever, muscle twitching and confusion. If they appear, get medical help right away.
Write down why you want to change before the appointment. For what a change of medication involves in general, see how switching antidepressants works .
Is Cymbalta harder to stop than Lexapro?
No trial we found compared stopping the two directly. What differs is half-life: about 12 hours for duloxetine, against 27 to 32 hours for escitalopram. So duloxetine levels fall faster after a missed or cut dose. Both labels recommend lowering the dose gradually rather than stopping suddenly, and both list similar withdrawal symptoms.
Lilly pooled six short duloxetine trials in which treatment stopped abruptly. 44% on duloxetine reported withdrawal symptoms, against 23% on placebo. Dizziness was the most common, then nausea and headache. By the end of the studies, some symptoms had not yet gone. Those that did go most often went within a week.
The Cymbalta label notes symptoms after both sudden and gradual stops. Its capsules are swallowed whole and not opened, a point to raise if you and your prescriber plan to come off it. The coating protects the drug from stomach acid, so the label says not to chew, crush or open them.
Don't stop either drug on your own. Note any symptoms after a missed dose and bring them to your prescriber. For what it can feel like, see what Cymbalta withdrawal feels like .
What should you ask your prescriber when choosing between Lexapro and Cymbalta?
Come with what matters most to you and what happened on past medications. What weighs more, pain or anxiety, shapes the choice. So do side effects you could not live with and how a past stop went. A short list lets the appointment cover these in a few minutes.
It helps to tell them:
Whether pain, anxiety or low mood bothers you most, and where any pain is. Side effects you had on any past antidepressant, and which you most want to avoid. Your blood pressure and any heart condition. How much alcohol you drink, and any liver problems. Every medication you take, including migraine medicines, blood thinners, painkillers and antibiotics such as ciprofloxacin. How stopping a past antidepressant went, and how often you miss doses.
And it helps to ask which side effects should prompt a call, and which usually ease on their own.
Both labels carry a boxed warning about suicidal thoughts in children, teens and young adults. If you're having thoughts of harming yourself, contact emergency services or a crisis line straight away. In the US, call or text 988. In the UK, call Samaritans on 116 123. Elsewhere, find a crisis line near you .
Once you start, short daily notes make the follow-up visit easier. The withClaro app lets you log how you feel each day and see side effects next to your dose.
Download on the App Store Choosing between Lexapro and Cymbalta comes down to how you feel on each one. The withClaro app lets you log mood, energy, sleep and side effects each day, linked to your dose, and turns them into a report for your prescriber.
Frequently asked questions Can Cymbalta and Lexapro be used together? The Cymbalta label warns that taking it with SSRIs such as Lexapro raises the risk of serotonin syndrome. If you've been given both, ask your pharmacist to review the combination.
Why do people stop taking Cymbalta? Side effects are a common reason. In Cymbalta's depression trials, about 8% stopped because of them, against about 5% on placebo, and nausea led the list. If a side effect is the problem, write down when it started and tell your prescriber before you stop.
Is Lexapro or Cymbalta stronger? Neither one is stronger for every person. Their doses sit on different scales, so a bigger number of milligrams doesn't mean a stronger drug. Ask your prescriber what dose range they expect for you, and why.
Why do I feel so good on Cymbalta? Feeling better is what the treatment aims for, and some people notice more energy as mood lifts. A high that comes with racing thoughts, little need for sleep or risky plans is different. The Cymbalta label warns that it can set off mania in people prone to it. If that sounds like you, tell your prescriber what you've noticed.
What is the downside of Cymbalta? Next to Lexapro, it brings more nausea at the start and a small rise in blood pressure. It also has a liver warning with heavy drinking, and its levels fall faster after a missed dose. Ask for a blood pressure check at the start and at follow-up visits.
Related articles
More about Lexapro More about Cymbalta Comparisons
Sources Lexapro (escitalopram) prescribing information and medication guide, Allergan, FDA label revised October 2023 CYMBALTA (duloxetine) prescribing information, Eli Lilly and Company, revised August 2023 Khan A, et al. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. Clinical Drug Investigation, 2007 Lam RW, et al. Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials. International Clinical Psychopharmacology, 2008 Pigott TA, et al. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Current Medical Research and Opinion, 2007 Cipriani A, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder. Lancet, 2018 Slee A, et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet, 2019 Petimar J, et al. Medication-induced weight change across common antidepressant treatments. Annals of Internal Medicine, 2024 Clayton A, et al. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. Journal of Sexual Medicine, 2007 Perahia DG, et al. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder. Journal of Affective Disorders, 2005
withClaro articles are for self-monitoring and educational purposes only. They are not a medical device, therapist, or diagnostic tool, and do not replace care from your prescribing clinician. If you are in crisis, contact your care team, emergency services, the Samaritans (UK: 116 123), or the Crisis Text Line (US: text HOME to 741741).